Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5048580016 | Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5048581017 | Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline hydrochloride 125 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Is a | Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has precise active ingredient | Tetracycline hydrochloride | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has basis of strength substance (attribute) | Tetracycline hydrochloride | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has precise active ingredient | Metronidazole (substance) | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has basis of strength substance (attribute) | Metronidazole (substance) | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has precise active ingredient | Bismuth biskalcitrate (substance) | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has basis of strength substance (attribute) | Bismuth biskalcitrate (substance) | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline hydrochloride 125 mg oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets